Summary
A patient with primary plasma cell leukemia (PCL) is presented who had an excellent response to high-dole cyclophosphamide and prolonged survival. The sole cytogenetic abnormality detected in the bone marrow was monosomy 18. Although this karyotypic aberration has been previously described in PCL, it generally occurs associated with additional abnormalities. The peripheral blood plasma cells from this patient reacted intracellularly with the monoclonal antibody OKM-1, which binds to myeloid cells at and above the level of myelocytes and to monocytes. This finding supports a common precursor cell for plasma cells and cells of the myelomonocytic lineage.
Similar content being viewed by others
References
Alexanian R (1985) Diagnosis and management of multiple myeloma. In: Wiernik PH, Canellos GP, Kyle RA, Schiffer CA (eds) Neoplastic diseases of the blood, Churchill Livingstone, New York, Edinburgh, London, Melbourne, pp 529–552
anderson J, Osgood EE (1965) Acute plasmocytic leukemia responsive to cyclophosphamide. J Am Med Assoc 193:844–848
Bayard ED, Hall BE (1948) Unusual remission after radiophosphorus therapy in a case of acute plasma cell leukemia. Blood 3:1019–1024
Bichel J, Effersoe P, Gormsen H, Harboe N (1952) Leukemic myelomatosis (plasma cell leukemia): a review with report of four cases. Acta Radiol 37:196–207
Das KC, Aikat BK (1967) Chromosomal abnormalities in multiple myeloma. Blood 30:738–748
Dewald GW, Kyle RA, Hicks GA, Greipp PR (1985) The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 66:380–390
Foa P (1904) Sulla produzione cellulaire nell'inflamazione ed in altri processi analoghi specialmente in cio che si riferisce alle plasmacellule. Folia haematol 1:166–167
Foon KA, Todd RF III (1986) Immunologic classification of leukemia and lymphoma. Blool 68:1–31
Gailani S, Seon BK, Henderson ES (1977) Plasma cell leukemia: response to conventional myeloma therapy. J Med 8:403–414
Kyle RA, Noel P (1986) Plasma cell leukemia: response to therapy in 43 cases. Blood 68:239a
Kyle RA, Maldonado JE, Bayrd ED (1974) Plasma cell leukemia. Report of 17 cases. Arch Intern Med 133:813–818
Mitelman F (1983) Catalogue of chromosome abberations in cancer. Cytogenet Cell Genet 36:1–515
Montecucco C, Richardi A, Merlini G, Ascari E (1986) Complete remission in plasma cell leukemia. Br J Haematol 62:525–527
Osanto S, Muller HP, Schuit HRE, Van Nieuwkoop JA, Willemze R (1983) Primary plasma cell leukemia: a case report and a review of the literature. Acta Haematol 70:122–129
Paietta E, Goldstein M, Papenhausen P, Ciobanu N, Wiernik PH (1985) Transformation of myeloma into Ph1-negative CML with plasma cell antigens. Am J Hematol 19:289–292
Phillips P (1980) Chromosomes of monoclonal gammopathies. Cancer Genet Cytogenet 2:79–86
Phillips P, Killman SA (1980) 14q+A consistent marker of plasma cell leukemia. Hereditas 93:185
Pruzanski W, Platts ME, Ogryzlo MA (1969) Leukemic form of immunocytic dyscrasia (plasma cell leukemia). A study of 10 cases and a review of the literature. Am J Med 47:60–74
Seabright M (1971) A rapid banding technique for human chromosomes. Lancet II:971–972
Shaw M, Twele TW, Nordquist RF (1974) Plasma cell elukemia: detailed studies and response to therapy. Cancer 33:619–625
Toma VA, Retief FP, Potgieter GM, anderson JD (1980) Plasma cell leukemia: Diagnostic problems in our experience with 11 cases. Acta Haematol 63:136–145
Warner NL, Moore MAS, Metcalf D (1969) A transplantable myelomonocytic leukemia in BALB/c mice: Cytology, karyotype and muramidase content. J Natl Cancer Inst 43:963–982
Woodruff RK, Malpas JS, Paxton AM, Lister TA (1978) PLasma cell leukemia (PCL): a report on 15 patients. Blood 52:839–845
Wright SD, Rao PE, Van Vorrhis WC, Craigmyle LS, lida K, Talle MA, Westberg EF, Goldstein G, Silverstein SC (1983) Identification of the C3bi receptor of human leukocytes and macrophages by using monoclonal antibodies. Proc Natl Acad Sci USA 80:5699–5703
Wurster-Hill DH, McIntyre OR, Cornwell GG, Maurer LH (1973) Marker chromosome 14 in multiple myeloma and plasma cell leukemia. Lancet II:1031
Author information
Authors and Affiliations
Additional information
Supported in part by grant from the Chemotherapy Foundation
Supported in part by a grant from the Stratton Foundation
Rights and permissions
About this article
Cite this article
Wiernik, P.H., Sciortino, D., Paietta, E. et al. Plasma cell leukemia with an unusual karyotype and prolonged survival following oral alkylating agent therapy. J Cancer Res Clin Oncol 113, 495–497 (1987). https://doi.org/10.1007/BF00390045
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00390045